PhRMA
AUGUST 29, 2022
We are committed to engaging a wide range of audiences and having a dialogue on opportunities to create a better health care system. We believe health literacy can not only help patients make appropriate decisions about their own health but also help enable constructive conversations on how we can support a regulatory and policy environment that helps patients access life-saving medications.
Drug Topics
AUGUST 31, 2022
Drug Topics® is joined by Joseph Mann, MSN, FNP-C, to discuss pharmacy’s fast-expanding role in COVID care, variant BA.5’s diagnostic impact, and the benefits of different tests available — including how technology behind a smartphone-integrated home test creates a fluid experience for patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
SEPTEMBER 2, 2022
AI-based technologies are increasingly being used for things such as virtual screening, physics-based biological activity assessment, and drug crystal-structure prediction.
IDStewardship
SEPTEMBER 2, 2022
In this article an expert in clinical information design provides his insights, discussing reasons why some guidelines do not get used along with solutions to these problems. Interview with: Michael Long, Ph.D. Interview by: Timothy Gauthier, Pharm.D., BCPS, BCIDP. Article Posted 2 September 2022. Recently The Joint Commission released an update to the elements of performance on Medication Management standard 09.01.01 which has to do with antimicrobial stewardship programs in hospitals.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PhRMA
SEPTEMBER 1, 2022
There’s been a lot of discussion this year about the Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) for new Alzheimer’s treatments finalized earlier this year in April. Their policy, finalized this past April, puts in place barriers between Alzheimer’s patients in Medicare and potentially life-changing treatment.
Drug Topics
AUGUST 29, 2022
Using electronic medical record data from 2018-2020 obtained from 24 medical centers across the US, including Johns Hopkins, University of Colorado, and Mayo Clinic institutions, a new study suggests rates of youth onset type 2 diabetes increased 77% during the first year of the pandemic.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Store News
SEPTEMBER 1, 2022
Seventy percent of pharmacists who responded to EnlivenHealth's survey said that a third or more of their pharmacy's revenue comes from Medicare-eligible patients.
STAT
SEPTEMBER 2, 2022
Sometime this weekend or early next week, pharmacies and doctors’ offices are going to start to receive Covid-19 boosters that have been reformulated to include protection against one of the sub-variants of Omicron. These boosters, from Pfizer and its partner BioNTech as well as from Moderna, are bivalent shots. They target two strains of the SARS-CoV-2 virus, both the original strain that all previous vaccines have protected against, and the Omicron sub-variants BA.4/BA.5.
Drug Topics
SEPTEMBER 1, 2022
Survey participants said their drug costs have gone up and almost a third had trouble paying for food and housing because of high drug costs.
Pharmacy Times
AUGUST 30, 2022
Analysis from the Johns Hopkins Children’s Center and University of Colorado indicates that cancellation of sports and a switch to virtual learning likely increased this risk.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Store News
SEPTEMBER 1, 2022
The membership warehouse club has revealed that its net sales climbed 15.3% to top $70.8 billion and shoppers rang up $222.7 billion in net sales, a 15.9% increase from fiscal 2021.
pharmaphorum
AUGUST 31, 2022
Kaiku Health’s year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma is being extended, according to the two partners. The original agreement last year focused on melanoma patients who are receiving BRAF/MEK combination therapies – specifically Novartis’ Tafinlar (dabrafenib) and Mekinist (trametinib) drugs – and has resulted in the development of a digital module tailored to their needs.
Drug Topics
AUGUST 29, 2022
New research looks at the potential benefits of long-term statin use in patients who are at increased risk of cardiovascular disease.
Pharmacy Times
SEPTEMBER 2, 2022
DNA and RNA sequencing could provide insight about resistance to chemotherapy in patients suffering from triple-negative breast cancer.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
SEPTEMBER 1, 2022
As the country heads for its third autumn and winter with Covid-19, the forecasts are not auspicious. Given how transmissible the SARS-CoV-2 virus is, models anticipate more than 100,000 additional deaths by the time next summer rolls around. The toll will depend on whether new variants emerge and how humans behave. Will many Americans, for example, decide to get the new, Omicron-tailored booster that could be available as soon as this weekend?
Drug Store News
SEPTEMBER 1, 2022
Walmart and Sustainable Beef will work collaboratively to increase visibility in the beef supply chain and help ranchers grow their business.
Drug Topics
SEPTEMBER 2, 2022
Continued advocacy work is the key to seeing state and federal legislative action come to fruition.
Pharmacy Times
AUGUST 28, 2022
Although innovation in the pharmacy space is continuing nearly 3 years into the COVID-19 pandemic, provider status and reimbursement are both necessary to continue this innovation in the future.
STAT
SEPTEMBER 2, 2022
I have worn many hats professionally. The most uncomfortable one is “doctor friend.” At best, it’s a request for a recommendation for a gynecologist or for advice on which antihistamine works best for allergies. But other times I have found myself in the role of interpreter between a friend and their physician, navigating serious health problems.
Pharmaceutical Technology
SEPTEMBER 2, 2022
Novo Nordisk has signed a definitive agreement for the acquisition of clinical-stage biopharmaceutical firm Forma Therapeutics for $20 for each share in cash or a total equity price of $1.1bn. Forma focuses on researching, developing and marketing new therapies for patients with sickle cell disease (SCD), rare hematologic diseases and cancers. Through the acquisition, Novo Nordisk plans to boost its presence in sickle cell disease and rare blood disorders.
Drug Topics
SEPTEMBER 1, 2022
This recall of propofol because of particulates seen in vials follows a previous one in July 2022.
Pharmacy Times
AUGUST 30, 2022
Hospitalization and interprofessional team management, particularly the involvement of a pharmacist, are essential in vaccination coverage for patients with diabetes.
PharmaVoice
AUGUST 30, 2022
The Community Alliance Network is the latest industry initiative looking to the pharmacy counter to help improve trial recruitment diversity.
STAT
AUGUST 31, 2022
The Food and Drug Administration on Wednesday authorized new Covid booster shots from Moderna and Pfizer that more closely match the strains of the coronavirus that are currently circulating in the U.S. Pfizer’s booster, made with partner BioNTech, is being authorized for people as young as 12 years old. The Moderna booster is being authorized for people ages 18 and up.
Drug Topics
AUGUST 30, 2022
This National Immunization Awareness Month, prepare your pharmacy to offer important vaccines.
Pharmacy Times
AUGUST 27, 2022
At the National Association of Chain Drug Stores (NACDS) 2022 Total Store Expo, Pharmacy Times spoke with Danny Sanchez, senior vice president and general manager of EnlivenHealth.
Drug Store News
AUGUST 30, 2022
In this latest installment of the Watch DSN video series, editor in chief Nigel Maynard, spoke with Tony Clapsis, senior vice president of Clinical Trial Services at CVS Health.
STAT
AUGUST 31, 2022
Despite a recent taxpayer-subsidized boon , the hospital industry spent the last several months lobbying for additional federal dollars amid warnings about the continued spread of Covid-19 and inflation’s impact on the nation’s health care system. Those efforts bore fruit: Medicare recently granted hospitals the largest price increase since 1998.
Drug Topics
AUGUST 30, 2022
More women are using medical cannabis for menopause-related symptoms.
Pharmacy Times
SEPTEMBER 1, 2022
Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses how pharmacy technicians can face burnout and advocate for themselves.
PharmaVoice
AUGUST 29, 2022
A collaboration between Stanford University researchers and Komodo Health aims to advance knowledge of lingering COVID symptoms, health disparities and intervention strategies.
STAT
SEPTEMBER 2, 2022
WASHINGTON — Rahul Gupta is no stranger to the nationwide addiction crisis. Drug use and overdose defined his tenure as the top health official in West Virginia, arguably the state hardest hit by the epidemic, and before that as the health officer in the state’s largest county.
Drug Topics
SEPTEMBER 2, 2022
The debate continues about the protective effect of eyeglasses against contracting the COVID-19 virus. Researchers from Denmark reported that their results were inconclusive regarding whether wearing eyeglasses is linked with a decreased risk of COVID-19 infections.
Pharmacy Times
SEPTEMBER 2, 2022
The FDA approved Azurity Pharmaceutical’s omeprazole and sodium bicarbonate for oral suspension to treat benign gastric ulcers and it is predicted to reach commercial markets by next year.
Expert insights. Personalized for you.
260 
Let's personalize your content